Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best emerging technology stocks to buy right now. The company develops ...

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...

The 2025 State of B2B Pipeline Growth Survey from Pipeline360 revealed how marketers are navigating the challenges and opportunities of pipeline growth in today’s business landscape. The survey found ...

AGOURA HILLS, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ('OTLC' or the 'Company'), a ...

Emerging Surgical Site Infections therapies in the different phases of clinical trials are- Ciprodiazole, DFA-02, ZuraPrep, ...

Pipeline Insight, 2025 ” explores a dynamic portfolio of emerging therapies poised to redefine management. Next-generation ...

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Complicated Urinary Tract Infections - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report provides extensive ...

The bipolar disorder clinical trial landscape is evolving with 25+ therapies, namely, KarXT (BMS), RAP 219 (Rapport Therapeutics), ABBV-932 (AbbVie Inc.), ABX-002 (Autobahn Therapeutics), ALTO-100 ...

MARIN COUNTY, Calif. (KRON) — Pacific Gas & Electric is conducting a series of tests on a new temporary gas line that was installed this weekend underneath Highway 101 in Novato. The pipeline was ...

(MENAFN- GlobeNewsWire - Nasdaq) Explore the future of Complicated Urinary Tract Infections (cUTIs) treatment with the "Pipeline Insight, 2025" report. Delve into over 10 companies and 12+ drugs in ...